Studies of spherical nanoengineered drug delivery systems have suggested that particle size and mechanical properties are key determinants of in vivo behavior; however, for more complex structures, detailed analysis of correlations between in vitro characterization and in vivo disposition are lacking. Anisotropic materials in particular bear unknowns in terms of size tolerances for in vivo clearance and the impact of shape and rigidity. Herein, we employed cylindrical polymer brushes (CPBs) to answer questions related to the impact of size, length and rigidity on the in vivo behavior of PEGylated anisotropic structures, in particular their pharmacokinetics and biodistribution. The modular grafting assembly of CPBs allowed for the systematic tailoring of parameters such as aspect ratio or rigidity while keeping the overall chemical composition the same. CPBs with altered length were produced from polyinitiator backbones with different degrees of polymerization. The side chain grafts
consisted of a random copolymer of poly[(ethylene glycol) methyl ether methacrylate] (PEGMA) and poly(glycidyl methacrylate) (PGMA), and rendered the CPBs water-soluble.
The epoxy groups of PGMA were subsequently reacted with propargylamine to introduce alkyne groups, which in turn were used to attach radiolabels via copper(I)-catalyzed alkyneazide cycloaddition (CuAAC). Radiolabeling allowed the pharmacokinetics of intravenously injected CPBs to be followed as well as their deposition into major organs post dosing to rats.
To alter the rigidity of the CPBs, core-shell-structured CPBs with polycaprolactone (PCL) as a water-insoluble and crystalline core and PEGMA-co-PGMA as the hydrophilic shell were synthesized. This modular build-up of CPBs allowed their shape and rigidity to be altered, which in turn could be used to influence the in vivo circulation behavior of these anisotropic polymer particles. Increasing the aspect ratio or altering the rigidity of the CPBs led to reduced bioavailability, higher clearance rates and, increased mononuclear phagocytic system (MPS) organ deposition.
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grafting-from, PEGylation, biodistribution, long circulation, pharmacokinetics, anisotropic polymer particles, macrophages Molecular weight, polymeric architecture, interfacial properties and particle size have been well described as key drivers of the in vivo behavior of nanomaterials and have motivated many in vitro 1-5 and in vivo studies of nanoparticle properties. [6] [7] [8] [9] [10] [11] [12] [13] The majority of these studies have focused on spherical systems; however, recently the focus has increasingly shifted toward anisotropic structures in order to establish the influence of shape and geometry of particulate carrier systems on their in vivo performance. [14] [15] [16] [17] It has been shown that particle geometry influences interactions with cells, and can alter the circulation of particles that may improve bioavailability and pharmacological effects. Although some non-spherical systems, including viruses, 18, 19 silica or gold rods, 20, 21 carbon nanotubes, [22] [23] [24] stretched polymer spheres 15 and PRINT particles 25, 26 have been studied, showing in vivo half-lives ranging from minutes to several hours (~12 h), thus far there have only been a small number of reports on the in vivo behavior of anisotropic polymer particles. This is, in part, a result of challenges associated with the production of non-spherical particles with precise control over both morphology and physicochemical properties. In this regard, cylindrical polymer brushes (CPBs) provide new opportunities to better understand the relationships between size, shape, rigidity and in vivo behavior since they are essentially unimolecular polymers, but can be synthesized to exhibit particle-like dimensions. CPBs, sometimes referred to as molecular brushes, are anisotropic polymers that can be synthetically assembled via several established grafting strategies. 27, 28 CPBs generally exhibit a polymer backbone that is grafted with polymer side chains. The use of controlled polymerization techniques gives excellent control over the composition of the CPBs while also enabling the precise tailoring of their morphology, such as length and diameter. With increasing grafting density of the side chains, steric hindrance of the grafts forces the backbone to stretch, which in turn results in the characteristic cylindrical shape of CPBs. To date, only a small number of in vitro reports [29] [30] [31] [32] have described potential biomedical applications of cylindrical polymer particles, 33 showing composition-dependent cellular interactions and strategies to release drugs to kill cancer cells.
Recently, small PEG bottlebrushes have been assembled into larger PEG star polymers to deliver anticancer drugs in vivo. 34 However, CPBs have been largely overlooked in terms of their potential in biomedicine. 35 In particular, the in vivo pharmacokinetic behavior of these materials has not been described, despite previous studies revealing that worm-shaped cylindrical polymer micelles show extended circulation half-lives when compared to stealth polymersomes. 36, 37 Herein, we sought to investigate the in vivo behavior of CPBs and to evaluate the impact of changes to length and rigidity on in vivo clearance, distribution and persistence (half-life). To that end, a library of CPBs containing poly[(ethylene glycol) methyl ether methacrylate] (PEGMA) as the main structural component was synthesized (Scheme 1 and in Supporting Information S1). CPBs of this type have advantages over other anisotropic materials such as cylindrical micelles since they allow the generation of anisotropic polymer particles while maintaining good control over length distribution. Thus CPBs can be produced with narrow length distributions and an overall length below 2 µm, a goal that remains challenging via self-assembly of block copolymers, despite efforts using crystallization 38, 39 or extrusion. 38 PEG-based materials were employed in our study to impart a hydrophilic corona to the system, thereby reducing opsonization and avoiding rapid uptake by the mononuclear phagocyte system (MPS). Small amounts of epoxy groups were incorporated into the PEGMA grafts to allow for postmodification reactions and, in this work, to facilitate stable conjugation with tritiated aspirin to allow quantification of in vivo pharmacokinetics. In order to alter the rigidity of the CPBs, we also integrated a hydrophobic core compartment into two of the CPB analogues. To the best of our knowledge, in vivo data for CPBs have not been reported to date. The current studies therefore provide the first confirmation of long circulatory behavior for these materials and suggest that whilst increasing length and rigidity increases clearance by the major MPS organs (liver, spleen), CPBs with molecular weights as high as 500 000 000 g·mol -1 still provide for high longevity in vivo with terminal half-lives of greater than 20 h. Spherical PEGylated dendrimers may achieve higher terminal half-lives in vivo (up to ~80 h), however, their molecular weights are far smaller (below 70 000 g·mol -1 ) than the studied CPBs. 40 Furthermore, the synthetic assembly of CPBs is useful for producing low-fouling materials that consist almost solely of PEG, which would not be possible via traditional self-assembly approaches. Hence, CPBs offer an interesting platform for the study of pharmacokinetics and biodistribution of cylindrical polymer objects, as their dimensions can be readily tailored by polymerization. Understanding the in vivo behavior of engineered particles, such as particle clearance and biodistribution, is a crucial step in establishing the potential usefulness of polymeric drug carriers. 
RESULTS AND DISCUSSION
Synthesis of the Water-Soluble CPBs. As illustrated in Scheme 1 (and in the Supporting Information S1), we combined several polymerization techniques to obtain a library of CPBs with tailor-made characteristics. Firstly, PHEMA was produced by the polymerization and subsequent deprotection of trimethylsilyl-protected HEMA (TMS-HEMA). Two different synthetic routes were used. For short PHEMA backbones (degree of polymerization (DP) ~100), it was sufficient to use controlled radical polymerization, in this case ATRP.
However, for longer PHEMA backbones (DP > 1000), anionic polymerization was employed to obtain a high DP while maintaining sufficient control over the molecular weight distribution. Secondly, PHEMA (a) was either modified with an ATRP initiator (b), to give Consequently, several water-soluble CPBs with different lengths were obtained (Table 1) . modification and grafting step can be found in the Supporting Information (S1). NMR of purified brush solutions revealed the successful copolymerization of GMA and PEGMA, and hence the incorporation of epoxy groups into the side chains ( Figure 1 ). Glycidyl methacrylate containing polymers have been reported to be highly versatile for postfunctionalization. 41, 42 Consequently, the CPBs were further treated with AF647 cadaverine dye to introduce fluorescent tags or reacted with propargylamine to modify some of the glycidyl methacrylate units with alkyne functionalities. IR measurements indicated the successful incorporation of alkyne groups into the polymer brushes (Supporting Information S2). These alkyne groups were then used to attach radiolabels ( Table 1 gives an overview of the lengths of the CPBs measured by AFM. The main difference between the CPBs with the same backbone length is that one type of CPB was synthesized with a water-insoluble crystalline core (PCL), whereas the other type lacks the core completely. It is noted that the curved structure of the adsorbed brushes can make it difficult to determine their exact length in some cases. The CPBs produced from backbones with the same DP had comparable lengths and length distributions. However, their appearance on mica (and probably also in solution) was quite different (Supporting Information S5). While [PCL 25 -b-(PEGMA 98 -co-GMA 16 )] 2700 ( Figure 2B ) and [PEGMA 188co-GMA 32 ] 2700 ( Figure 2C ) appeared to be quite similar on mica, the difference in appearance between [PCL 14 -b-(PEGMA 94 -co-GMA 16 )] 7500 ( Figure 2E ) and [PEGMA 170 -co-GMA 28 ] 7500 ( Figure 2F ) was more pronounced. The CPBs bearing a PCL core compartment appeared less coiled. The PCL core is expected to provide the respective brush with more rigidity and hence reduces the degree of coiling of the brush. DSC measurements further confirmed the PCL brush crystallizes between 24 -28 ºC (Supporting Information S6). In an aqueous environment, PCL is insoluble and this property should further contribute to the stiffness of the particles. [43] [44] [45] In addition, core-shell CPBs containing PCL as core material are able to form a crystalline core. 46, 47 Figure 2B and 2E show the CPBs [PCL 25 -b-(PEGMA 98co-GMA 16 )] 2700 and [PCL 14 -b-(PEGMA 94 -co-GMA 16 )] 7500 , respectively. Both CPBs appear relatively more rigid when compared to their counterparts without the PCL core ( Figure 2C and 2F). Particularly [PEGMA 170 -co-GMA 28 ] 7500 shows a significantly more undulated structure compared to [PCL 14 -b-(PEGMA 94 -co-GMA 16 )] 7500 . The same phenomenon was observed for brushes deposited from aqueous solution (Supporting Information S7).
In Vitro Cell Association of CPBs. To investigate the cell association of CPBs, we incubated AF647-labeled CPBs with in vitro cultured macrophages (RAW264.7) at different brush concentrations for 24 h. Flow cytometry was used to quantify cell association ( Figure 3F ).
The overall cell association was rather low, considering the high polymer concentration (0.2 g·L -1 ). While [PEGMA 140 -co-GMA 21 ] 112 ( Figure 3F , blue column) and [PEGMA 188 -co-GMA 32 ] 2700 ( Figure 3F , black column) showed almost the same amount of cellular interaction, the association of the longest CPBs [PEGMA 170 -co-GMA 28 ] 7500 ( Figure 3F , gray column) was almost three times higher (~30%). It is has been shown that particle shape and size may impact attachment and internalization. 4 Lowering the polymer brush concentration reduced the cell association even further (below 5%, see Supporting Information S8).
Deconvolution microscopy confirmed the low cell association ( Individual pharmacokinetic parameters were calculated using WinNonlin PK modeling software and summary parameters are shown in Table 2 . behavior previously reported for self-assembled filomicelle materials. 37 That study showed an increase in systemic circulation time with increasing length. 2 µm filomicelles were reported to have a circulation half-life of approximately 2 days, whereas the 18 µm analogues showed more than double that (approximately 4.5 days). However, the conclusion drawn for the filomicelle materials, which are not necessarily stable to shear forces due to their selfassembled nature, was that the filomicelles broke down over time and smaller fragments were phagocytosed, while the remainder remained in circulation. The result of this was that although some residual fragments of the longest (18 μm) filomicelles could still be detected up to 7 days post dosing, this was not due to the longer filomicelles completely evading recognition. We attribute the observation of the opposite trend here for the CPBs to the stability of the CPB backbone when compared with the self-assembled cylindrical micelles.
Increasing the Brush Aspect Ratio Increases Plasma
Thus, the backbone stability of the CPBs makes the model of steady attrition of the highest aspect ratio materials unlikely to apply. In turn, this leads to the outcome of increasing size giving rise to increased splenic filtration and phagocytic clearance by the cells of the MPS.
This difference in behavior is supported by the finding that filomicelles with a cross-linked core were cleared within hours as opposed to days. 37 Although no length dependent behavior was described for their cross-linked materials, the finding suggests that cross-linked cylindrical objects behave differently to those that are self-assembled and not further stabilized post-assembly.
Increasing Brush Aspect Ratio Results in Increased Deposition in MPS Organs. The in
vivo biodistribution of the CPBs in major organs (brain, heart, kidney, liver, lung, pancreas, and spleen) was determined by analyzing 3 H in tissues harvested 24 h post dosing at 5 mg/kg.
The percentage of injected 3 H recovered in tissues is given in Figure 4C . As expected, the most significant uptake was evident in the spleen and liver, supporting a mechanism of MPS recognition and clearance. 48, 49 Panel B gives the organ uptake normalized per gram of organ tissue and demonstrates the relative efficiency of splenic filtration in the clearance of CPBs of all lengths. This is not unexpected since the molecular weight and polymeric architecture of the, albeit unimolecular, CPBs is sufficient to push them to behave in a manner that is particle-like. The systemic clearance of polymers is thought to proceed by two different mechanisms, depending on molecular weight. Below ~48 kDa the renal clearance of small molecules leads to reduced exposure. 50 At sizes above the renal clearance limit and where phagocytosis is inhibited by PEGylation, long circulation behavior is commonly evident.
However, as the size approaches ~150-200 nm, particle-like behavior leads to increased MPS recognition and filtration by the spleen. 51 Studies of particles of varying size have generally shown that increased particle size correlates to increased clearance rates, although this finding is better understood for spherical systems. 52 Examples of anisotropic materials are much more limited. In terms of in vivo behavior, CPBs appear to exhibit what could be described as classic particle-like behavior, despite being themselves unimolecular entities. This is in contrast to what has been shown recently for hydrophilic carbon nanotubes, which were excreted into urine within 4 h, despite being relatively rigid and having lengths on a micrometer scale. 50 These contrasting data suggest that the mechanisms of clearance of anisotropic material are likely to be highly material dependent, among other factors. Increasing CPB Rigidity Decreases Plasma Residence Time. Figure 5A contrasts 7500 . The PCL core is not soluble in water and leads to more cylindrical and less random coiled structures with increased rigidity (Figure 2, Figure S6 ). The rigidified brushes showed differences in both clearance and volume of distribution, and these trends were most apparent for the largest construct ([PCL 14 -b-(PEGMA 94 -co-GMA 16 7500 20.4 ± 5.0 3.4 ± 0.5 92.6 ± 6.7 [PCL 25 -b-(PEGMA 98 -co-GMA 16 )] 2700 26.4 ± 9.8 2.7 ± 0.7 92.9 ± 8.0 [PCL 14 -b-(PEGMA 94 -co-GMA 16 )] 7500 18.9 ± 5.4 8.9 ± 1.3 225.0 ± 36.3 the differences in volume of distribution and clearance may increase 3 H in the liver after 24 h, particularly for the longer CPBs. In contrast, there was no evidence for increased uptake in the spleen.
The high uniformity and stability of the CPBs may offer advantages in more predictable behavior in vivo compared with self-assembled materials. The high degree of control that is possible in terms of architecture and functionalization is attractive in an area where control over cargo loading, release and organ deposition profile is critical. The in vivo data reported herein provide a first step toward the realization of this potential, and show that relatively large CPBs can be constructed with long circulatory half-lives, which is consistent with the potential for accumulation in tumors via the enhanced permeability and retention (EPR) effect. 53 Previous studies have shown that CPBs may be drug loaded with high efficiency. 31,32 Images were processed with Imaris (Bitplane) using the maximum intensity projection. Brushes (CPBs) . The CPBs were synthesized through the combination of various polymerization techniques, such as anionic, ring opening and atom transfer radical polymerization. The stepwise build-up from a polyinitiator backbone to a CPB is explained in detail below. Table S1 in the Supporting Information (S10) gives an overview of the synthesized CPBs used in this study.
Preparation of the Cylindrical Polymer

Synthesis of Polymer Backbones.
The PHEMA backbones were obtained through deprotection of various poly(2-(trimethylsiloxy)ethyl methacrylate) (PTMS-HEMA). The PTMS-HEMA backbones were either synthesized via anionic polymerization, as previously reported by Mori and coworkers 54 or via ATRP according to a procedure of Matyjaszewski and coworkers. 55 The deprotection to PHEMA was performed in methanol using acetic acid (90/10 v/v). In the following, PHEMA was either used directly as a polyinitiator for the ROP of CL or modified to an ATRP polyinitiator. To introduce ATRP initiators, PHEMA was reacted with a 1.5-fold molar excess of 2-bromoisobutyryl bromide in either anhydrous pyridine (for backbones with DP = 2700 and 7500) or in anhydrous THF (for the short backbone) containing a 2-fold molar excess of triethylamine (TEA). was cooled to 12 °C. Samples were loaded in batches of 12 to prevent significant temperature changes during the course of the measurements. Tissue samples from untreated rats were also processed using the same method to provide a background count for equivalent masses of each tissue type.
Synthesis of Cylindrical Polymer
The acquired raw data was used to establish an efficiency value for each sample using the following equation:
(eq. 1)
where spiked tissue dpm is the radioactivity measured in the spiked sample, tissue dpm,uncorr is the radioactivity in the unspiked sample, and spike solution dpm is the known amount of radioactivity added to the spiked sample. The calculated efficiency value was used to correct the dpm value for each measured sample to eliminate the effect of quenching, which may have resulted from sample processing. This was done using the following relationship:
(eq. 2)
where tissue dpm,corr is taken to give the true sample activity. The activity of the whole organ was calculated based on the fraction of total organ mass contained within the measured sample.
Whole Blood Sample Processing. One sample from each duplicate set of whole blood samples (50 μL) taken at each time point was spiked with a known amount of 4azidosalicylic acid [ring-5-3 H] to correct for efficiency in the manner described above. All samples were then treated with a 1:1 mixture of Soluene 350:IPA and held at 60 °C overnight.
After cooling to room temperature the samples were bleached with hydrogen peroxide (30% w/v, 2 x 100 μL) and Ultima Gold (10 mL) was added as described above. Samples were left at 4 °C, in the dark, without agitation for at least 96 h before being measured in the same manner as described for tissue samples. The measured activity values were corrected for efficiency using the relationships shown in equation 2.
